Folate-targeted nanoparticles for rheumatoid arthritis therapy

Area of Science:

• Immunology
• Nanotechnology
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a prevalent inflammatory autoimmune disease impacting joints globally.
• Current RA therapies lack optimal efficacy, necessitating novel treatment strategies.
• Activated macrophages in the synovial membrane play a key role in RA pathogenesis.

Purpose of the Study:

• To review the potential of folic acid-targeted nanoparticles for RA therapy.
• To explore the targeting of activated macrophages via folate receptor beta (FRβ).
• To discuss nanoparticle stealth properties for evading mononuclear phagocytic system clearance.

Main Methods:

• Review of current literature on RA pathogenesis and nanoparticle drug delivery.
• Focus on folic acid (FA) and its receptor (FRβ) on activated macrophages.
• Analysis of nanoparticle design, including stealth characteristics.

Main Results:

• Activated macrophages in RA express FRβ, enabling targeted uptake of FA-coupled nanoparticles.
• Nanoparticles can be engineered for stealth properties to prolong circulation and target macrophages.
• FA-targeted nanoparticles represent a promising drug delivery system for RA treatment.

Conclusions:

• Folic acid-targeted nanoparticles show significant potential for delivering therapeutic agents to macrophages in RA.
• Optimizing nanoparticle stealth is crucial for effective targeting and therapeutic outcomes.
• This approach offers a prospective strategy for improved RA management.